Anorectic ọgwụ ọjọọ "Fepranon", "Reduxine", "Meridia", "ebughibu." Ọgwụ ndị na-ebelata agụụ

Kwa afọ enwekwu nsogbu nke ngafe arọ na nwanyi. Ọtụtụ mgbalị ifelata ọgwụgwụ ọtụtụ mgbe dịghị mma Ọnọdụ. Dị iche iche diets, ikike omumu, liposuction ọ bụghị mgbe nile iduga irè-arụpụta. Otu ụzọ dị irè isi na arọ ọnwụ na-anorectic ọgwụ ọjọọ. Ha belata agụụ site na-emetụta ndị agụụ center.

Pụtara na-ebelata agụụ

Anorectic ọgwụ - a otu nke bekee na-ebelata agụụ site na-emetụta ndị Central ụjọ usoro. Na ụbụrụ na e nwere ógbè ndị agụụ na satiety. Drugs na otu a nwere a na-akpali akpali utịp ke saturation center, ma n'otu oge inhibit agụụ center. Mmetụta na CNS emee site ìgwè serotonin na nọrepinefrini na hypothalamus. N'ihi na nke a na e nwere a ọnụ mmetụta nke agụụ.

Anorectic ọgwụ ndị na-ebelata agụụ, na-ekewa n'ime stimulators nke adrenergic stimulants na serotonergic systems jikọtara n'aka.

egosi

Nke a na ụdị ọgwụ ọjọọ na-weere na dị iche iche nke ibu oké ibu. Ndị a gụnyere:

• ibu oké ibu metụtara na oké nri oriri n'ime ahu (alimentary);
• ìgwè nke arọ na mmiri ọgwụ ọdịda (eji na Nchikota na ndị ọzọ ọgwụ ọjọọ);
• ibu oké ibu, hypothyroidism;
• ngafe ibu na-apụghị na-emeso ndị ọzọ n'aka.

Ọgwụ ndị na-ebelata agụụ, ga-a na nnabata na nri, na-eji na-ebu ọnụ ụbọchị.

Contraindications na mmetụta

Anorectic ọgwụ ọjọọ ga-eji nditịm n'okpuru dọkịta iwu, dị ka ndị a ọgwụ ọjọọ eme ihe na-contraindicated n'ihi na ụfọdụ ndị. Nke ọrịa kwesịghị ịṅụ n'aka otu a:

• na ọbara mgbali na oké;
• thyrotoxicosis;
• malignancies;
• myocardial infarction ma ọ bụ ọrịa strok na anamnesis;
• odida nke obi;
• ọbara ọrịa;
• glaucoma;
• ọnọdụ epilepticus.

Ọzọkwa contraindications bụ ọrịa uche na-enweghị nchịkwa na Filiks ke Central ụjọ usoro, imeju na-na akụrụ odida, ehighi ura na ime.

N'ihe banyere ihe ovadozu ndị a ọgwụ ọjọọ nwere ike ike ọgwụgwụ, ọgbụgbọ, vomiting, akọrọ ọnụ, afọ ọsịsa, ma ọ bụ afọ ọsịsa, urination ọrịa, nchegbu, dizziness, mụbara ọbara mgbali, oké sweating, nfụkasị Jeremaya dị ka urticaria ma ọ bụ angioedema.

Mgbe ndị a mgbaàmà ga belata dose nke ọgwụ. Ọ bụrụ na mgbaàmà na-agbanwebeghị, ọ dị mkpa ozugbo iji kagbuo ọgwụ na ịkpọ dọkịta gị iji dozie ọgwụgwọ.

Ọgwụ "Meridia"

The price nke a pụtara adị ọtụtụ mara mma. Mgbe 700-800 rubles, jiri ya tụnyere ndị ọzọ yiri ọgwụ ọjọọ - na ọ bụ ọnụ. Ndị a mbadamba ndị dị irè na mbenata arọ ahụ, nwere a ngwa ngwa mmetụta. The ọgwụ umi bụ ìgwè nke anorectics, enwekwu mmetụta nke ozuzù. Ọ nkanka na reuptake nke serotonin, nọrepinefrini, dopamine, na-eme a ọgwụgwọ mmetụta nke ọgwụ ahụ. Ji ibu oké ibu na-anọghị nke concomitant daa ọrịa, ọnụnọ nke lipid metabolism ọrịa na-arịa ọrịa shuga mellitus ụdị.

"Meridia" na-agbala na gelatin capsules 10 na 15 mg, 14 iberibe na otu mkpọ. Contraindications na-enweta ọgwụ bụ ọgwụ ekweghị ibe nọrọ otu a, ụjọ na ọrịa uche, mmiri ọgwụ ọdịda ke idem, obi na vaskụla ọrịa, ọrịa akụrụ, imeju na-na thyroid gland.

Belata ịdị arọ nke ahụ nwere ike na-ewere 1 Capsule kwa ụbọchị 10 mg. Ọ bụrụ na ọgwụ na-ọma etinye obi gị dum, kwa ụbọchị dose nwere ike mụbara ruo 15 mg. The ọgwụgwọ ekwesịghị gafere 1 afọ. Mbadamba "Meridia", onye price - 700 rubles maka 14 capsules, nwere ike zụrụ site ọgwụ.

"Reduxine"

Nke a Nchikota ọgwụ, mgbe inhibiting agụụ center n'ihi metabolites na rụọ ọrụ center nke saturation. The na nkà mmụta ọgwụ na-iwere 1 Capsule kwa ụbọchị. The dose na-kenyere n'otu n'otu dabere na ogo nke ibu oké ibu na izugbe ala nke organism. N'ọnọdụ ka ukwuu, ọ bụ 10 mg. Mbadamba "Reduxine" ga-eri na-enweghị ịta, na-aṅụ ọtụtụ mmiri.

Egosi ka ha were na ibu oké ibu na-anọghị nke concomitant daa ọrịa, ọnụnọ nke lipid metabolism ọrịa na-arịa ọrịa shuga mellitus ụdị.

Mbadamba "Reduxine" kwesịghị ji mee ihe maka ime na lactating inyom, ndị mmadụ na pathologies nke ụfọdụ akụkụ. Na nke a, ọ dị mkpa iji ịkpọ a ọkachamara. Ọgwụ e nyere na nnabata na ndị ọchịchị nke ụbọchị na nri.

Ọgwụ "Fepranon": ntuziaka maka ojiji

Nke a anorectic ọgwụ, nke bụ n'ọrụ mgwa - amfepramone. Ọrụ ọ na etiti nke saturation, egbochi agụụ center, enwekwu excretion nke na-enweghị isi bekee na-ebelata ibu ibu. Drug ọrụ na-egosipụta site na 1 hour ọ na-eme ka 8 awa banye n'ime ọma site na ọbara-ụbụrụ na placental mgbochi.

Egosi maka ọgwụ - alimentary ibu oké ibu na lipid metabolism ruru ka mmiri ọgwụ disruptions. Mgbe thyroid gland na-eji na Nchikota na thyroid ọgwụ.

1 mbadamba nwere 25 mg nke nọ n'ọrụ umi. N'abalị mkpa ka ị na-aṅụ 80 mg, ntụgharị 1 mbadamba 2-3 ugboro n'ụbọchị. Ha kwesịrị ịna-aṅụ ọkara otu awa tupu nri. The kacha oge nke n'ikuku - 2 ọnwa, nwere ike ugboro ugboro mgbe 3 ọnwa. The ọgwụ na-agbala na na ndenye ọgwụ.

Na ihe ovadozu nke "Fepranon" nwere ike ime ngwa ngwa obi otiti na-eku ume, ịmụ anya arọ nrọ, ida. Ọ bụrụ na ị-aṅụ ọgwụ maka àkwụkwụ, ọdụdọ nwere ike iwe, n'ihi ya, mgbe a ụdị ọrịa kwesịrị igbochi oriri.

Ọgwụ "ebughibu"

Nke a pụtara iji belata arọ, ọgwụ mmetụta nke na-enweta site na-arụsi ọrụ umi sibutramine. Mmetụta na-ahụ na-adị site na ebighị nke satiety center, na-ebelata mmetụta nke agụụ na ụdi ala oriri nke nri. Ọzọkwa, ọgwụ metabolism na-enwekwu ndị ọzọ ngwa ngwa mwepụ of bekee site ahụ.

"Ebughibu" na-eji na alimentary ibu oké ibu, ibu oké ibu na-arịa ọrịa shuga na lipid ọrịa. The ọgwụ na-contraindicated na-esonụ mgbe:

• maka ụjọ na ọrịa uche;
• ibu oké ibu metụtara na mmiri ọgwụ disruptions;
• ọrịa obi na ọbara arịa;
• daa ọrịa nke imeju, akụrụ, thyroid;
• riri ma ọ bụ ndị aṅụrụma;
• n'ihi na ndị mmadụ n'okpuru afọ 18;
• ime na lactating inyom.

Ọ bụghị nnọọ na-ọma anabata ahụ "ebughibu." Nyocha slimming show na ọgwụ nwere mmetụta dị ka digestive ọrịa, isi ọwụwa, iro ụra, dizziness, ọtụtụ mgbe mmalite nke ọgwụgwọ. Ọ bụrụ na i nwere ndị a mgbaàmà kwesịrị ịkpọ a ọkachamara banyere discontinuation nke ọgwụ.

"Ebughibu" dị na mbadamba nkume nke 10 na 15 mg, na onunu ogwu nke 1 mbadamba kwa ụbọchị. na-amalite usoro ọgwụgwọ na 10mg ma ọ bụrụ na mmetụta na-nti, mgbe ahụ, dose nwere ike mụbara ruo 15 mg na imeta a mmetụta dị mma na a mkpumkpu oge.